Skip to main content

News

First Report Managed Care
Compared with those with private insurance, participants in breast cancer clinical trials with Medicare, Medicaid, or other government insurance were less likely to complete trials and had a lower survival rate.
First Report Managed Care
Most clinical trials supporting US Food and Drug Administration approval of drugs for metastatic breast cancer over the past 13 years did not meet thresholds for substantial clinical benefit on two of three established measures, according to research presented at the San Antonio Breast Cancer…
First Report Managed Care
“Several neoadjuvant and adjuvant treatment options exist for patients with HER2-positive stage II to III breast cancer. Recent results of the KATHERINE trial showed that adjuvant T-DM1 can reduce distant recurrence risk in patients without pathologic complete response (pCR) after neoadjuvant…
Pharmacy Learning Network
It was recently confirmed in a 72 to 18 Senate vote that Dr Stephen Hahn will be the new head of the FDA.
Annals of Long-Term Care
“Based on the current evidence, hypothyroidism is significantly associated with increased all-cause mortality instead of cardiovascular mortality among the elderly,” researchers of a study concluded.
Pharmacy Learning Network
Among individuals with depression, a recent study shows that the prevalence of cannabis use has increased significantly.
Population Health Learning Network
By Reuters Staff(Reuters) - A print advertisement of Alkermes Plc's addiction treatment, Vivitrol, is false or misleading as it omits important risk information associated with its use, the Food and Drug Administration said in a warning letter http://bit.ly/2LGVKUM to the company.
Population Health Learning Network
By David DouglasNEW YORK (Reuters Health) - Withdrawing antidepressant drugs in people who have recovered from a chronic or recurrent major depressive episode during pharmacologic treatment alone or in combination with cognitive-behavioral therapy (CBT) is linked with a higher recurrence risk, even…
Population Health Learning Network
By Gene Emery(Reuters Health) - Curing the vitamin D deficiency of a patient in the intensive care unit (ICU) doesn't improve their odds of survival or recovery, a new study of 1,078 seriously-ill people has concluded.
Veterans Health Today
“Concerns of hyperkalemia and protein inadequacy related to plant-based diets may be outdated and unsupported by the current body of literature,” researchers concluded.
Back to Top